GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (TSXV:AVCR) » Definitions » Cyclically Adjusted PS Ratio

Avricore Health (TSXV:AVCR) Cyclically Adjusted PS Ratio : 1.25 (As of May. 29, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Avricore Health Cyclically Adjusted PS Ratio?

As of today (2025-05-29), Avricore Health's current share price is C$0.05. Avricore Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was C$0.04. Avricore Health's Cyclically Adjusted PS Ratio for today is 1.25.

The historical rank and industry rank for Avricore Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSXV:AVCR' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.22   Med: 3.07   Max: 12
Current: 1.43

During the past years, Avricore Health's highest Cyclically Adjusted PS Ratio was 12.00. The lowest was 0.22. And the median was 3.07.

TSXV:AVCR's Cyclically Adjusted PS Ratio is ranked better than
59.09% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.06 vs TSXV:AVCR: 1.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Avricore Health's adjusted revenue per share data for the three months ended in Dec. 2024 was C$0.016. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is C$0.04 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Avricore Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Avricore Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Cyclically Adjusted PS Ratio Chart

Avricore Health Annual Data
Trend Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 10.59 5.35 1.57

Avricore Health Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.35 3.83 4.96 5.32 1.57

Competitive Comparison of Avricore Health's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Avricore Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Avricore Health's Cyclically Adjusted PS Ratio falls into.


;
;

Avricore Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Avricore Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.05/0.04
=1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avricore Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Avricore Health's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.016/127.3637*127.3637
=0.016

Current CPI (Dec. 2024) = 127.3637.

Avricore Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.000 99.789 0.000
201506 0.000 100.500 0.000
201509 0.008 100.421 0.010
201512 0.003 99.947 0.004
201603 0.032 101.054 0.040
201606 0.009 102.002 0.011
201609 0.027 101.765 0.034
201612 0.001 101.449 0.001
201703 0.008 102.634 0.010
201706 0.012 103.029 0.015
201709 0.006 103.345 0.007
201712 -0.018 103.345 -0.022
201803 0.005 105.004 0.006
201806 0.005 105.557 0.006
201809 0.000 105.636 0.000
201812 -0.008 105.399 -0.010
201903 0.000 106.979 0.000
201906 0.000 107.690 0.000
201909 0.000 107.611 0.000
201912 0.000 107.769 0.000
202003 0.000 107.927 0.000
202006 0.000 108.401 0.000
202009 0.000 108.164 0.000
202012 0.000 108.559 0.000
202103 0.000 110.298 0.000
202106 0.000 111.720 0.000
202109 0.001 112.905 0.001
202112 0.000 113.774 0.000
202203 0.000 117.646 0.000
202206 0.002 120.806 0.002
202209 0.006 120.648 0.006
202212 0.010 120.964 0.011
202303 0.006 122.702 0.006
202306 0.006 124.203 0.006
202309 0.010 125.230 0.010
202312 0.014 125.072 0.014
202403 0.011 126.258 0.011
202406 0.010 127.522 0.010
202409 0.012 127.285 0.012
202412 0.016 127.364 0.016

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avricore Health  (TSXV:AVCR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Avricore Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Avricore Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.
Executives
Kiriaki Smith Senior Officer
Rodger Mckendry Seccombe Senior Officer
Alan Arnstein Director
David Farnfield Director
David M. Hall Director
Inc. Emerald Health Therapeutics 10% Security Holder
Sukhwinder Singh Rai Director

Avricore Health Headlines

No Headlines